Gabriel V, Lincoln A, Zdyrski C, Ralston A, Wickham H, Honold S
Heliyon. 2024; 10(7):e28420.
PMID: 38590903
PMC: 10999936.
DOI: 10.1016/j.heliyon.2024.e28420.
Hoshino T, Onodera S, Kimura M, Suematsu M, Ichinohe T, Azuma T
Med Mol Morphol. 2023; 56(3):159-176.
PMID: 37012505
DOI: 10.1007/s00795-023-00351-2.
Peng T, Sun Y, Lv Z, Zhang Z, Su Q, Wu H
Sci Rep. 2021; 11(1):1373.
PMID: 33446698
PMC: 7809464.
DOI: 10.1038/s41598-020-80146-y.
Perera S, Kelly D, OKane G
Curr Oncol. 2020; 27(Suppl 3):S165-S172.
PMID: 33343210
PMC: 7739521.
DOI: 10.3747/co.27.7159.
Liu Y, Cao M, Cai Y, Li X, Zhao C, Cui R
Front Cell Dev Biol. 2020; 8:95.
PMID: 32154250
PMC: 7044267.
DOI: 10.3389/fcell.2020.00095.
Evaluation of top-down mass spectrometry and ion-mobility spectroscopy as a means of mapping protein-binding motifs within heparin chains.
Zhao Y, Kaltashov I
Analyst. 2020; 145(8):3090-3099.
PMID: 32150181
PMC: 7160044.
DOI: 10.1039/d0an00097c.
FGF19- Signaling in Hepatocellular Carcinoma.
Raja A, Park I, Haq F, Ahn S
Cells. 2019; 8(6).
PMID: 31167419
PMC: 6627123.
DOI: 10.3390/cells8060536.
Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor.
Davis J, Alghanmi A, Gundampati R, Jayanthi S, Fields E, Armstrong M
Arch Biochem Biophys. 2018; 654:115-125.
PMID: 30031837
PMC: 6152824.
DOI: 10.1016/j.abb.2018.07.017.
How the Body Talks to the Brain; Peripheral Mediators of Physical Activity-Induced Proliferation in the Adult Hippocampus.
Bolijn S, Lucassen P
Brain Plast. 2018; 1(1):5-27.
PMID: 29765833
PMC: 5939189.
DOI: 10.3233/BPL-150020.
Effect of extension of the heparin binding pocket on the structure, stability, and cell proliferation activity of the human acidic fibroblast growth factor.
Davis J, Gundampati R, Jayanthi S, Anderson J, Pickhardt A, Koppolu B
Biochem Biophys Rep. 2018; 13:45-57.
PMID: 29556563
PMC: 5857160.
DOI: 10.1016/j.bbrep.2017.12.001.
Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence hybridization (FISH) to select the optimal patients for matched therapy?.
Chae Y, Arya A, Chiec L, Shah H, Rosenberg A, Patel S
Oncotarget. 2017; 8(59):100863-100898.
PMID: 29246028
PMC: 5725070.
DOI: 10.18632/oncotarget.19809.
Current and Future Perspectives in Craniosynostosis.
Kang S, Kang J
J Korean Neurosurg Soc. 2016; 59(3):247-9.
PMID: 27226856
PMC: 4877547.
DOI: 10.3340/jkns.2016.59.3.247.
Mechanism of FGF receptor dimerization and activation.
Sarabipour S, Hristova K
Nat Commun. 2016; 7:10262.
PMID: 26725515
PMC: 4725768.
DOI: 10.1038/ncomms10262.
Fibroblast growth factors 7 and 10 are involved in ameloblastoma proliferation via the mitogen-activated protein kinase pathway.
Nakao Y, Mitsuyasu T, Kawano S, Nakamura N, Kanda S, Nakamura S
Int J Oncol. 2013; 43(5):1377-84.
PMID: 24002438
PMC: 3823399.
DOI: 10.3892/ijo.2013.2081.
Craniofacial surgery, from past pioneers to future promise.
Wan D, Kwan M, Kumar A, Bradley J, Longaker M
J Maxillofac Oral Surg. 2012; 8(4):348-56.
PMID: 23139542
PMC: 3454104.
DOI: 10.1007/s12663-009-0084-x.
Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET.
Placone J, Hristova K
PLoS One. 2012; 7(10):e46678.
PMID: 23056398
PMC: 3467271.
DOI: 10.1371/journal.pone.0046678.
The physical basis of FGFR3 response to fgf1 and fgf2.
Chen F, Hristova K
Biochemistry. 2011; 50(40):8576-82.
PMID: 21894939
PMC: 3398506.
DOI: 10.1021/bi200986f.
The A391E mutation enhances FGFR3 activation in the absence of ligand.
Chen F, Degnin C, Laederich M, Horton W, Hristova K
Biochim Biophys Acta. 2011; 1808(8):2045-50.
PMID: 21536014
PMC: 3110564.
DOI: 10.1016/j.bbamem.2011.04.007.
FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
Xu B, Tong N, Chen S, Hua L, Wang Z, Zhang Z
BMC Cancer. 2011; 11:84.
PMID: 21349172
PMC: 3049742.
DOI: 10.1186/1471-2407-11-84.
FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism.
He L, Shobnam N, Wimley W, Hristova K
J Biol Chem. 2011; 286(15):13272-81.
PMID: 21324899
PMC: 3075674.
DOI: 10.1074/jbc.M110.205583.
